Mesmerize Expands its Point of Care Network with HomeTown Pharmacy Partnership
NEW YORK, April 21, 2022 /PRNewswire/ -- Mesmerize (www.mesmerize.com), a prominent out-of-home media company specializing in patient education at the...
Day: April 22, 2022
OSIS and WELL Health Partner to Offer 60+ Community Health Centers Best-In-KLAS Patient Communications Capabilities
Partnership Brings Together Two HIT Leaders to Enhance Digital Patient Communications for Underserved Populations SANTA BARBARA, Calif., April 21, 2022...
TMRW LIFE SCIENCES NAMED FAST COMPANY’S #1 MOST INNOVATIVE BIOTECH COMPANY FOR GROUND-BREAKING IVF TECHNOLOGY
Fertility Tech Pioneer Modernizing IVF With Safer, Trackable and Transparent Frozen Egg and Embryo Management Tops 2022 List of Companies...
Zocdoc Reports: A Year in Allergies
Zocdoc booking trends point to more Americans seeking help to manage their allergies, and a continued return to in-person care...
icometrix’s MRI measures for people with Multiple Sclerosis receive Medtech Innovation briefing from the National Institute for Health and Care Evidence (NICE)
LONDON, April 21, 2022 /PRNewswire/ -- icometrix, the worldwide leader in digital health technology solutions for neurological conditions, announced the...
Meridian Shines a Light on Cyberbullying and Encourages Michigan Youth to Make a Difference
DETROIT, April 21, 2022 /PRNewswire/ -- In today's world of technology, many youth experience the negative consequences of increased connectivity...
Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time
ROSEVILLE, Minn., April 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call...
XpertDox Announces Exclusive Partnership with Urgent Care for Children to Implement Autonomous Medical Coding
XpertDox has entered an exclusive partnership with Urgent Care for Children USA (UC4C) to provide XpertCoding, an autonomous medical coding...
Veeva Vault CTMS Launched at Bristol Myers Squibb to Simplify Clinical Trial Processes Globally
Bringing together Bristol Myers Squibb and Celgene on one clinical trial management system, company goes live with Vault CTMS in...
NLS Pharmaceutics to Participate in the B. Riley Annual Neuro & Ophthalmology Investor Conference
ZURICH, SWITZERLAND / ACCESSWIRE / April 22, 2022 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss...
Healthcare Executive Craig W. Abbott Named President & CEO of Saint Therese
SAINT LOUIS PARK, MN / ACCESSWIRE / April 22, 2022 / The Saint Therese Board of Directors has completed its...
CureVac to Report Fourth Quarter and Full-Year 2021 Financial Results and Business Updates on April 28, 2022
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 22, 2022 / CureVac N.V. (NASDAQ:CVAC), a biopharmaceutical company developing a...
RxSight, Inc. to Present at the Bank of America Healthcare Conference
ALISO VIEJO, Calif., April 22, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to...
Northwell Health Collaborates with Teladoc Health to Improve System Wide Virtual Care
Combined Teladoc Health and Microsoft capabilities to be leveraged for improved patient carePURCHASE, NY, April 22, 2022 (GLOBE NEWSWIRE) --...
Assertio Holdings, Inc. to Report First Quarter 2022 Financial Results After the Close of Markets on Monday, May 9, 2022
LAKE FOREST, Ill., April 22, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced...
IO Biotech Hosting Key Opinion Leader Webinar Series
Part 1: A New Way to Kill Tumors–IO102-IO103 Phase 3 Trial in Combination with Anti-PD-1 in Advanced Melanoma Thursday, April...
Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer
SALT LAKE CITY, April 22, 2022 (GLOBE NEWSWIRE) -- Stella Diagnostics, Inc. (OTC: SLDX), a molecular diagnostics-based organization optimizing patient...
Salarius Pharmaceuticals, Inc. Announces $2.3 Million Registered Direct Offering
HOUSTON, April 22, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing cancer therapies for...
Medexus Pharmaceuticals Announces Resubmission of Treosulfan NDA
Additional data collection and analysis reconfirms confidence in New Drug Application for TreosulfanNDA resubmission date consistent with previously announced timelineFDA...
SCYNEXIS Announces Pricing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
JERSEY CITY, N.J., April 22, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the pricing of its underwritten...